How to store Sarilumab

Sarilumab is a human monoclonal antibody that binds to membrane-bound and soluble interleukin-6 (IL-6) receptor-alpha to inhibit IL-6 signaling. Salirumab is approved as monotherapy or in combination with csdmards for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have an inadequate response (IR) or intolerance (INT) to one or more csdmards.

Sarilumab contains the active substancesarilumab and is packaged as a colorless to pale yellow solution in single-dose prefilled syringes and single-dose prefilled pens, available in 150 mg and 200 mg injection solutions. The recommended dose is 200 mg subcutaneously administered once every two weeks, usually refrigerated in the original carton at 36-46°F (2-8°C) to avoid light, do not freeze, and do not shake. If desired, patients/caregivers may store Salirumab in the outer carton at room temperature up to 77°F (25°C) for up to 14 days. Do not store above 77°F (25°C). Use Salirumab within 14 days after removal from the refrigerator or discard.

The patent drug Thalilutumab is a new type of drug for treating diseases. It is not yet on the market in China, and therefore it is not covered by medical insurance. The common dosage form of Salirutumab's original drug is injection, which has been marketed overseas. The price of the European version of the specification200mg*2 per box is around 17,500 (the price may fluctuate due to the exchange rate). There are currently no generic Salirutumab produced in other countries.